198 related articles for article (PubMed ID: 15699142)
1. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.
Berko D; Carmi Y; Cafri G; Ben-Zaken S; Sheikhet HM; Tzehoval E; Eisenbach L; Margalit A; Gross G
J Immunol; 2005 Feb; 174(4):2116-23. PubMed ID: 15699142
[TBL] [Abstract][Full Text] [Related]
2. Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin.
Margalit A; Sheikhet HM; Carmi Y; Berko D; Tzehoval E; Eisenbach L; Gross G
J Immunol; 2006 Jan; 176(1):217-24. PubMed ID: 16365413
[TBL] [Abstract][Full Text] [Related]
3. Maximizing immune responses: the effects of covalent peptide linkage to beta-2-microglobulin.
Bauer SM; Williams MA; Howell AP; Schwarz E; Smith ES; Zauderer M
Oncol Res; 2008; 17(5):205-16. PubMed ID: 18980017
[TBL] [Abstract][Full Text] [Related]
4. Binding of H-2Kb-specific peptides to TAP and major histocompatibility complex class I in microsomes from wild-type, TAP1, and beta2-microglobulin mutant mice.
Wang P; Raynoschek C; Svensson K; Ljunggren HG
J Biol Chem; 1996 Oct; 271(40):24830-5. PubMed ID: 8798757
[TBL] [Abstract][Full Text] [Related]
5. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
Michaëlsson J; Achour A; Rölle A; Kärre K
J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
[TBL] [Abstract][Full Text] [Related]
6. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.
Cafri G; Sharbi-Yunger A; Tzehoval E; Alteber Z; Gross T; Vadai E; Margalit A; Gross G; Eisenbach L
Mol Ther; 2015 Aug; 23(8):1391-1400. PubMed ID: 25997427
[TBL] [Abstract][Full Text] [Related]
7. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
Benoit LA; Tan R
J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
[TBL] [Abstract][Full Text] [Related]
8. An allosteric mechanism controls antigen presentation by the H-2K(b) complex.
Gakamsky DM; Boyd LF; Margulies DH; Davis DM; Strominger JL; Pecht I
Biochemistry; 1999 Sep; 38(37):12165-73. PubMed ID: 10508421
[TBL] [Abstract][Full Text] [Related]
9. A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficiently.
Sylvester-Hvid C; Nielsen LL; Hansen NJ; Pedersen LO; Buus S
Scand J Immunol; 1999 Oct; 50(4):355-62. PubMed ID: 10520174
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and thermodynamics of beta 2-microglobulin binding to the alpha 3 domain of major histocompatibility complex class I heavy chain.
Hebert AM; Strohmaier J; Whitman MC; Chen T; Gubina E; Hill DM; Lewis MS; Kozlowski S
Biochemistry; 2001 May; 40(17):5233-42. PubMed ID: 11318646
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of P1A35-43/beta2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model.
Zhang X; Mei W; Zhang L; Yu H; Zhao X; Fan X; Qian G; Ge S
Oncol Rep; 2009 Nov; 22(5):1213-20. PubMed ID: 19787242
[TBL] [Abstract][Full Text] [Related]
13. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
14. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
Lev A; Novak H; Segal D; Reiter Y
J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
[TBL] [Abstract][Full Text] [Related]
16. Differential association of beta2-microglobulin mutants with MHC class I heavy chains and structural analysis demonstrate allele-specific interactions.
Shields MJ; Hodgson W; Ribaudo RK
Mol Immunol; 1999 Jun; 36(9):561-73. PubMed ID: 10499810
[TBL] [Abstract][Full Text] [Related]
17. Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis.
Wang M; Harhaji L; Lamberth K; Harndahl M; Buus S; Heegaard NH; Claesson MH; Nissen MH
Scand J Immunol; 2009 Mar; 69(3):203-12. PubMed ID: 19281532
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of recombinant single-chain salmon class I MHC fused with beta2-microglobulin with biological activity.
Zhao H; Stet RJ; Skjødt K; Savelkoul HF
Fish Shellfish Immunol; 2008 Apr; 24(4):459-66. PubMed ID: 18280180
[TBL] [Abstract][Full Text] [Related]
19. The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines.
Shields MJ; Kubota R; Hodgson W; Jacobson S; Biddison WE; Ribaudo RK
J Biol Chem; 1998 Oct; 273(43):28010-8. PubMed ID: 9774416
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
Tafuro S; Meier UC; Dunbar PR; Jones EY; Layton GT; Hunter MG; Bell JI; McMichael AJ
Eur J Immunol; 2001 Feb; 31(2):440-9. PubMed ID: 11180108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
